↧
Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse...
CINCINNATI, March 25, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, today...
View ArticleEnable Injections Presents Survey Results Highlighting Missed Opportunities...
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced...
View Article